查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1881437

止血劑市場－全球產業規模、佔有率、趨勢、機會和預測，按類型、劑型、應用地區和競爭格局分類，2020-2030年預測

Hemostats Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type, By Formulation, By Application Region and Competition, 2020-2030F
出版日期: | 出版商: TechSci Research | 英文 186 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

2024年全球止血劑市場規模為38.2億美元，預計2030年將以7.48%的複合年成長率成長至58.9億美元。止血劑是一種特殊的醫療器材或製劑，用於在外科手術、創傷或其他各種醫療情況下止血，其作用機制是透過促進凝血或提供機械屏障。全球止血劑市場成長的主要促進因素包括：全球外科手術量不斷增加、全球人口老化加劇導致更多慢性疾病患者需要接受手術治療，以及創傷病例的日益增加。

市場概覽
預測期 2026-2030
2024年市場規模 38.2億美元
2030年市場規模 58.9億美元
2025-2030年複合年成長率 7.48%
成長最快的細分市場 凝血酶類止血劑
最大的市場 北美洲

主要市場促進因素

主要市場挑戰

主要市場趨勢

目錄

第1章：產品概述

第2章：研究方法

第3章：執行概要

第4章：顧客之聲

第5章：全球止血劑市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 依類型（凝血酶型止血劑、氧化再生纖維素型止血劑、複方止血劑、明膠型止血劑、膠原蛋白型止血劑、其他止血劑）
    • 依劑型分類（基質和凝膠止血劑、片狀和墊狀止血劑、海綿止血劑、粉末止血劑）
    • 依應用領域（骨科手術、一般外科手術、神經外科手術、心血管外科手術、重建外科手術、婦科手術、其他外科手術應用）
    • 按地區
    • 按公司（2024 年）
  • 市場地圖

第6章：北美止血劑市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 北美洲：國家分析
    • 美國
    • 加拿大
    • 墨西哥

第7章：歐洲止血劑市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 歐洲：國家分析
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙

第8章：亞太地區止血劑市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 亞太地區：國家分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

第9章：中東和非洲止血劑市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 中東和非洲：國家分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

第10章：南美洲止血劑市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 南美洲：國家分析
    • 巴西
    • 哥倫比亞
    • 阿根廷

第11章：市場動態

  • 促進要素
  • 挑戰

第12章：市場趨勢與發展

  • 併購（如有）
  • 產品發布（如有）
  • 最新進展

第13章：全球止血劑市場：SWOT分析

第14章：波特五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商議價能力
  • 顧客的力量
  • 替代產品的威脅

第15章：競爭格局

  • Johnson & Johnson
  • Baxter International Inc.
  • Pfizer Inc
  • B Braun Medical Inc
  • Becton, Dickinson, and Company
  • Teleflex Incorporated
  • Medtronic Plc
  • Hemostasis, LLC
  • Stryker Corporation
  • Integra LifeSciences Corporation

第16章：策略建議

第17章調查會社について,免責事項

簡介目錄
Product Code: 22135

The Global Hemostats Market, valued at USD 3.82 Billion in 2024, is projected to experience a CAGR of 7.48% to reach USD 5.89 Billion by 2030. Hemostats are specialized medical devices or agents employed to arrest bleeding during surgical procedures, traumatic injuries, or in various medical conditions by promoting coagulation or providing a mechanical barrier. The global hemostats market growth is principally driven by an escalating volume of surgical interventions worldwide, a progressively aging global population prone to various chronic diseases requiring surgical treatment, and the rising incidence of trauma cases.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 3.82 Billion
Market Size 2030USD 5.89 Billion
CAGR 2025-20307.48%
Fastest Growing SegmentThrombin-Based Hemostats
Largest MarketNorth America

Key Market Drivers

The Global Hemostats Market is significantly influenced by the confluence of a growing geriatric population and continuous advancements in hemostatic technologies. The increasing proportion of older adults globally represents a substantial and expanding patient demographic requiring surgical intervention. This demographic often presents with multiple comorbidities, necessitating more frequent and complex procedures where effective bleeding control is paramount. For instance, according to a study highlighted by ResearchGate in August 2025, older individuals typically require surgical procedures four times more often than the younger population, directly increasing the demand for hemostatic agents during these interventions.

Key Market Challenges

The stringent and complex regulatory approval processes represent a significant impediment to the growth of the Global Hemostats Market. These rigorous requirements necessitate protracted development timelines and substantially increased costs for manufacturers. Such an environment diverts significant financial and human capital towards compliance rather than innovation, thereby slowing the introduction of novel hemostatic solutions to address unmet clinical needs.

Key Market Trends

The expanding adoption of minimally invasive surgical approaches significantly influences the global hemostats market by creating demand for specialized bleeding control solutions. These techniques, favored for enhanced patient recovery and reduced hospital stays, are increasingly applied across diverse surgical disciplines. According to the National Institutes of Health, over 1 million hip and knee arthroplasty procedures were performed annually in the U. S. in 2024, a large volume where minimally invasive techniques are increasingly utilized. This procedural shift necessitates hemostatic agents that are effective and precisely applicable within constricted surgical fields.

Key Market Players

  • Johnson & Johnson
  • Baxter International Inc.
  • Pfizer Inc
  • B Braun Medical Inc
  • Becton, Dickinson, and Company
  • Teleflex Incorporated
  • Medtronic Plc
  • Hemostasis, LLC
  • Stryker Corporation
  • Integra LifeSciences Corporation

Report Scope:

In this report, the Global Hemostats Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Hemostats Market, By Type:

  • Thrombin-based Hemostats
  • Oxidized Regenerated Cellulose-based Hemostats
  • Combination Hemostats
  • Gelatin-based Hemostats
  • Collagen-based Hemostats
  • Other Hemostats

Hemostats Market, By Formulation:

  • Matrix & Gel Hemostats
  • Sheet & Pad Hemostats
  • Sponge Hemostats
  • Powder Hemostats

Hemostats Market, By Application:

  • Orthopedic Surgery
  • General Surgery
  • Neurological Surgery
  • Cardiovascular Surgery
  • Reconstructive Surgery
  • Gynecological Surgery
  • Other Surgical Applications

Hemostats Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Hemostats Market.

Available Customizations:

Global Hemostats Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Hemostats Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Type (Thrombin-based Hemostats, Oxidized Regenerated Cellulose-based Hemostats, Combination Hemostats, Gelatin-based Hemostats, Collagen-based Hemostats, Other Hemostats)
    • 5.2.2. By Formulation (Matrix & Gel Hemostats, Sheet & Pad Hemostats, Sponge Hemostats, Powder Hemostats)
    • 5.2.3. By Application (Orthopedic Surgery, General Surgery, Neurological Surgery, Cardiovascular Surgery, Reconstructive Surgery, Gynecological Surgery, Other Surgical Applications)
    • 5.2.4. By Region
    • 5.2.5. By Company (2024)
  • 5.3. Market Map

6. North America Hemostats Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Type
    • 6.2.2. By Formulation
    • 6.2.3. By Application
    • 6.2.4. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Hemostats Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Type
        • 6.3.1.2.2. By Formulation
        • 6.3.1.2.3. By Application
    • 6.3.2. Canada Hemostats Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Type
        • 6.3.2.2.2. By Formulation
        • 6.3.2.2.3. By Application
    • 6.3.3. Mexico Hemostats Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Type
        • 6.3.3.2.2. By Formulation
        • 6.3.3.2.3. By Application

7. Europe Hemostats Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Type
    • 7.2.2. By Formulation
    • 7.2.3. By Application
    • 7.2.4. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Hemostats Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Type
        • 7.3.1.2.2. By Formulation
        • 7.3.1.2.3. By Application
    • 7.3.2. France Hemostats Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Type
        • 7.3.2.2.2. By Formulation
        • 7.3.2.2.3. By Application
    • 7.3.3. United Kingdom Hemostats Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Type
        • 7.3.3.2.2. By Formulation
        • 7.3.3.2.3. By Application
    • 7.3.4. Italy Hemostats Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Type
        • 7.3.4.2.2. By Formulation
        • 7.3.4.2.3. By Application
    • 7.3.5. Spain Hemostats Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Type
        • 7.3.5.2.2. By Formulation
        • 7.3.5.2.3. By Application

8. Asia Pacific Hemostats Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Type
    • 8.2.2. By Formulation
    • 8.2.3. By Application
    • 8.2.4. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Hemostats Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Type
        • 8.3.1.2.2. By Formulation
        • 8.3.1.2.3. By Application
    • 8.3.2. India Hemostats Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Type
        • 8.3.2.2.2. By Formulation
        • 8.3.2.2.3. By Application
    • 8.3.3. Japan Hemostats Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Type
        • 8.3.3.2.2. By Formulation
        • 8.3.3.2.3. By Application
    • 8.3.4. South Korea Hemostats Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Type
        • 8.3.4.2.2. By Formulation
        • 8.3.4.2.3. By Application
    • 8.3.5. Australia Hemostats Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Type
        • 8.3.5.2.2. By Formulation
        • 8.3.5.2.3. By Application

9. Middle East & Africa Hemostats Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Type
    • 9.2.2. By Formulation
    • 9.2.3. By Application
    • 9.2.4. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Hemostats Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Type
        • 9.3.1.2.2. By Formulation
        • 9.3.1.2.3. By Application
    • 9.3.2. UAE Hemostats Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Type
        • 9.3.2.2.2. By Formulation
        • 9.3.2.2.3. By Application
    • 9.3.3. South Africa Hemostats Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Type
        • 9.3.3.2.2. By Formulation
        • 9.3.3.2.3. By Application

10. South America Hemostats Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Type
    • 10.2.2. By Formulation
    • 10.2.3. By Application
    • 10.2.4. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Hemostats Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Type
        • 10.3.1.2.2. By Formulation
        • 10.3.1.2.3. By Application
    • 10.3.2. Colombia Hemostats Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Type
        • 10.3.2.2.2. By Formulation
        • 10.3.2.2.3. By Application
    • 10.3.3. Argentina Hemostats Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Type
        • 10.3.3.2.2. By Formulation
        • 10.3.3.2.3. By Application

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Hemostats Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Johnson & Johnson
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. Baxter International Inc.
  • 15.3. Pfizer Inc
  • 15.4. B Braun Medical Inc
  • 15.5. Becton, Dickinson, and Company
  • 15.6. Teleflex Incorporated
  • 15.7. Medtronic Plc
  • 15.8. Hemostasis, LLC
  • 15.9. Stryker Corporation
  • 15.10. Integra LifeSciences Corporation

16. Strategic Recommendations

17. About Us & Disclaimer